Today: 7 February 2026
Subscribe
Browse Category

NYSE:AMR News 17 December 2025 - 12 January 2026

AMR stock jumps after hedge fund stake filing — what’s next for Alpha Metallurgical Resources

AMR stock jumps after hedge fund stake filing — what’s next for Alpha Metallurgical Resources

New York, January 11, 2026, 19:55 (EST) — The market has closed. Alpha Metallurgical Resources’ shares ended Friday at $242.32, gaining 4.94%, following an investor filing that drew renewed attention to the U.S. metallurgical coal producer as the new week begins. (StockAnalysis) The disclosure is significant as AMR’s shares have been racing ahead in year-end positioning. Its early-January jump has drawn fresh funds into a market segment sensitive to steel demand and export prices. Alpha, a supplier of metallurgical coal essential for steel production, moves in line with the global demand cues shaping coking coal trade, regardless of any company-specific
12 January 2026
····
Alpha Metallurgical Resources (AMR) Stock Surges on Dec. 17, 2025: What’s Driving the Move, Insider Signals, and Analyst Forecasts

Alpha Metallurgical Resources (AMR) Stock Surges on Dec. 17, 2025: What’s Driving the Move, Insider Signals, and Analyst Forecasts

Alpha Metallurgical Resources, Inc. (NYSE: AMR) — one of the most closely watched U.S. metallurgical (coking) coal producers — is back in the spotlight on December 17, 2025, after a sharp move higher that has traders revisiting the company’s newly issued 2026 guidance and a fresh wave of insider-trading headlines. In Wednesday trading, AMR shares were up solidly, trading around the mid-$190s after opening near $190 and printing an intraday range that pushed toward the high-$190s. MarketBeat What follows is a full, publication-ready roundup of today’s news, forecasts, and analyses (17.12.2025) — including the key numbers from Alpha’s 2026 outlook,
17 December 2025
·····

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Go toTop